| Literature DB >> 30333333 |
Soumi Das1, Kakali Ghosh1, Avijit Hazra1, Chaitali Sen1, Anupam Goswami1.
Abstract
CONTEXT: Hyperglycemia has been found to occur during myocardial infarction and cardiac surgery even in nondiabetic patients. These being essentially stressful processes associated with hypoperfusion, we decided to find a possible relationship between the occurrence of global tissue hypoperfusion (GTH) and elevated blood glucose level in adult nondiabetic patients undergoing elective off-pump coronary artery bypass grafting (CABG). AIMS: This study aims to observe for the occurrence of global tissue hypoperfusion and its effect on blood glucose level and whether raised blood glucose level can be used as a marker for GTH.Entities:
Keywords: Hyperglycemia; hypoperfusion; nondiabetic; off-pump coronary artery bypass grafting
Mesh:
Substances:
Year: 2018 PMID: 30333333 PMCID: PMC6206810 DOI: 10.4103/aca.ACA_202_17
Source DB: PubMed Journal: Ann Card Anaesth ISSN: 0971-9784
Subject selection criteria and working definitions used in the study
| Category | Criteria and Definitions |
|---|---|
| Inclusion criteria[ | Adult subject of either sex aged between 35-70 years |
| Patients posted for elective off-pump CABG | |
| Ejection fraction ≥30% measured within 6 weeks before surgery | |
| Nondiabetic with HbA1C <6% | |
| Exclusion criteria[ | Left main stem coronary disease |
| Associated heart valve pathology | |
| Intraoperative cardiac arrest | |
| Massive perioperative bleeding | |
| Presence of preoperative intra-aortic balloon pump | |
| Presence of cardiogenic shock or arrest | |
| Preoperative vasopressor therapy | |
| Preoperative mechanical ventilation | |
| Unfavorable laboratory parameters, i.e., creatinine >133 µmol/L (2.4 mg/dL), total bilirubin >22 µmol/L (0.39 mg/dL), white blood cell count >12,000/µL, or platelet count <100,000 cells/µL immediately before surgery | |
| Working definitions | GTH: SvO2 <70% and arterial lactate level ≥2 mmol/L[ |
| Moderate GTH: SvO2 <70% and lactate ≥2- <4 mmol/L[ | |
| Severe GTH: SvO2 <70% and lactate ≥4 mmol/L[ | |
| Occult hypoperfusion: Moderate-to-severe GTH with MAP ≥65 mmHg, CVP ≥8 mmHg, and UO ≥0.5 mL/kg/h[ | |
| Overt tissue hypoperfusion: GTH with MAP <65 mmHg, CVP<8 mmHg and UO <0.5 mL/kg/h[ | |
| Time of mechanical ventilation: Time from arrival in ICU postoperatively to extubation | |
| Duration of ICU stay: Number of hours after surgery to discharge from ICU. Patients were discharged from ICU when apyrexial, hemodynamically stable and requiring minimal use of vasoactive medication; chest drain output <1.5 mL/kg/h[ | |
| Duration of hospital stay: Number of days after surgery to discharge from hospital[ | |
| Massive perioperative bleeding: Bleeding requiring either transfusion of ≥5 U whole blood or packed red blood cells within a 48-h period or reoperation after closure of sternotomy for the purpose of controlling bleeding (also known as BARC Type 4 [CABG-related] bleeding)[ | |
| Moderate-to-high dose inotrope use: Moderate inotrope support was defined by inotrope use 12-24 h and high dose inotrope support was defined by support >24 h in this study | |
| Renal dysfunction or failure: Serum creatinine increase >177 µmol/L (3.19 mg/dL), serum creatinine increase >50%, or dialysis requirement[ | |
| Prolonged ventilation: Ventilation after arrival in ICU for >24 h[ |
CABG: Coronary artery bypass grafting, HbA1c: Glycosylated hemoglobin, GTH: Global tissue hypoperfusion, SvO2: Mixed venous oxygen saturation, MAP: Mean arterial pressure, CVP: Central venous pressure, UO: Urine output, ICU: Intensive Care Unit, BARC: Bleeding Academic Research Consortium
Figure 1Global tissue hypoxia and tissue perfusion status of the study subjects. GTH: global tissue hypoxia/hypoperfusion, SvO2: Mixed venous oxygen saturation
Changes in mixed venous oxygen saturation, lactate and glucose levels in no global tissue hypoxia or hypoperfusion versus global tissue hypoxia or hypoperfusion subgroups over time
| GTH patients | Non-GTH patients | |||||
|---|---|---|---|---|---|---|
| SvO2 (%) | Lactate | Blood glucose | SvO2 (%) | Lactate | Blood glucose | |
| Preincision | ||||||
| Mean±SD | 63.33±4.27 | 2.56±0.25 | 128.50±12.85 | 76.64±7.07 | 1.26±0.82 | 108.57±18.24 |
| | 34.56 | 20.58 | 20.07 | 105.33 | 14.71 | 57.11 |
| df | 4 | 4 | 4 | 92 | 92 | 92 |
| Significance (two-tailed) | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| Postprotamine | ||||||
| Mean±SD | 61.44±6.89 | 4.17±1.12 | 166.00±24.14 | 79.42±7.68 | 3.42±1.92 | 165.00±23.82 |
| | 24.46 | 9.94 | 20.12 | 97.85 | 16.77 | 65.36 |
| df | 7 | 7 | 7 | 89 | 89 | 89 |
| Significance (two-tailed) | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| ICU baseline | ||||||
| Mean±SD | 59.87±6.75 | 4.94±1.75 | 184.00±7.89 | 78.54±7.38 | 4.14±1.92 | 167.73±25.33 |
| | 34.11 | 10.24 | 85.55 | 97.01 | 19.62 | 60.32 |
| df | 13 | 13 | 13 | 83 | 83 | 83 |
| Significance (two-tailed) | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| ICU 8 h | ||||||
| Mean±SD | 62.53±5.53 | 5.22±1.39 | 177.37±12.95 | 74.81±6.00 | 4.55±1.96 | 170.23±22.49 |
| | 71.96 | 26.00 | 92.94 | 82.24 | 15.43 | 48.47 |
| df | 46 | 46 | 46 | 41 | 41 | 41 |
| Significance (two-tailed) | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| ICU 24 h | ||||||
| Mean±SD | 62.48±4.97 | 3.05±0.95 | 147.94±19.23 | 70.81±7.92 | 2.68±1.63 | 151.10±17.70 |
| | 70.38 | 17.88 | 43.09 | 72.13 | 13.28 | 69.98 |
| df | 31 | 31 | 31 | 65 | 65 | 65 |
| Significance (two-tailed) | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
GTH: Global tissue hypoxia or hypoperfusion, SvO2: Mixed venous oxygen saturation, SD: Standard deviation, df: Degree of freedom, ICU: Intensive Care Unit
Figure 2Trend analysis in GTH patients
Figure 3Trend analysis in non-GTH patients
Relationship between postoperative outcome variables (nominal and ordinal data) and global tissue hypoxia or hypoperfusion patients: Results using ordinal logistic regression
| SE | Wald | df | Significance value | CI | ||
|---|---|---|---|---|---|---|
| GTH | 11.447 | 5.185 | 4.874 | 1 | 0.027 | 95% |
| ICU stay | 0.094 | 0.060 | 2.485 | 1 | 0.115 | 95% |
| Perioperative blood loss | 0.004 | 0.002 | 3.444 | 1 | 0.063 | 95% |
| Hospital stay | 3.164 | 0.808 | 15.349 | 1 | 0.000 | 95% |
| MODS score for day 1 | −9.705 | 0.000 | 1 | 95% | ||
| MODS score for day 2 | 0a | 0 | 95% |
aThis parameter is set to zero because it is redundant. df: Degrees of freedom, B: Parameter coefficient, Wald: Wald coefficient, SE: Standard error, CI: Confidence interval, GTH: Global tissue hypoxia or hypoperfusion, ICU: Intensive Care Unit, MODS: Multiple organ dysfunction score
Relationship between postoperative outcome variables (nominal and categorical data) and global tissue hypoxia or hypoperfusion patients: Results using logistic regression)
| SE | Wald | df | Significance value | Exp ( | CI | ||
|---|---|---|---|---|---|---|---|
| Duration of ventilation | 0.215 | 0.114 | 3.550 | 1 | 0.060 | 1.240 | 95% |
| Moderate-to-high dose of inotrope | 0.342 | 1.152 | 14.210 | 1 | 0.000 | 1.013 | 95% |
| cardiac shock | 0.485 | 27,998.549 | 0.000 | 1 | 1.000 | 1.625 | 95% |
| Constant | 0.210 | 27,998.550 | 0.000 | 1 | 1.000 | 1.233 | 95% |
Predicted probability is for GTH (outcome variable). Exp (B) equivalent to Odds Ratio. df: Degrees of freedom, B: Parameter coefficient, Wald: Wald coefficient, OR: Odds ratio, SE: Standard error, CI: Confidence interval, GTH: Global tissue hypoxia or hypoperfusion
Correlation of mixed venous oxygen saturation, lactate and glucose levels at various time points with postoperative outcome parameters
| Variables | Preincision | Postprotamine | ICU at arrival | ICU at 8 h | ICU at 24 h |
|---|---|---|---|---|---|
| SvO2 (%) | 75.84±7.61 | 77.80±9.18 | 75.74±9.88 | 67.67±8.62 | 68.06±8.08 |
| Duration of ventilation (h) | −0.270 (0.006) | −0.324 (0.001) | −0.398 (0.000) | −0.320 (0.001) | −0.318 (0.001) |
| ICU stay (h) | −0.263 (0.008) | −0.343 (0.000) | −0.390 (0.000) | −0.367 (0.000) | −0.427 (0.000) |
| Hospital stay (days) | −0.177 (0.077) | −0.209 (0.037) | −0.363 (0.000) | −0.336 (0.001) | −0.367 (0.000) |
| MODS day 1 | −0.056 (0.577) | −0.044 (0.665) | −0.090 (0.374) | −0.145 (0.150) | −0.275 (0.006) |
| MODS day 2 | −0.209 (0.037) | −0.186 (0.064) | −0.196 (0.051) | −0.129 (0.201) | −0.166 (0.099) |
| MODS day 4 | −0.162 (0.107) | −0.155 (0.123) | −0.138 (0.172) | −0.134 (0.183) | −0.117 (0.247) |
| Duration of inotrope use (h) | −0.192 (0.056) | −0.273 (0.006) | −0.428 (0.000) | −0.386 (0.000) | −0.431 (0.000) |
| Perioperative blood loss (mL) | −0.107 (0.289) | −0.096 (0.342) | −0.026 (0.796) | 0.014 (0.894) | 0.043 (0.669) |
| Lactate (mmol/L) | 1.33±0.85 | 3.48±1.87 | 4.25±1.91 | 4.84±1.65 | 2.80±1.45 |
| Duration of ventilation (h) | 0.076 (0.455) | 0.073 (0.468) | 0.108 (0.283) | 0.073 (0.473) | 0.083 (0.411) |
| ICU stay (h) | 0.050 (0.624) | 0.006 (0.956) | 0.030 (0.764) | −0.003 (0.975) | 0.037 (0.717) |
| Hospital stay (days) | −0.055 (0.588) | 0.046 (0.648) | 0.038 (0.710) | 0.075 (0.460) | 0.023 (0.824) |
| MODS day 1 | 0.171 (0.089) | −0.072 (0.475) | 0.021 (0.838) | 0.063 (0.535) | 0.052 (0.604) |
| MODS day 2 | 0.001 (0.990) | 0.114 (0.259) | 0.077 (0.448) | 0.092 (0.365) | 0.152 (0.131) |
| MODS day 4 | 0.145 (0.151) | 0.134 (0.184) | 0.141 (0.162) | 0.145 (0.151) | 0.115 (0.255) |
| Duration of inotrope use (h) | 0.081 (0.423) | 0.120 (0.234) | 0.102 (0.311) | 0.053 (0.602) | 0.100 (0.322) |
| Perioperative blood loss (mL) | −0.058 (0.569) | −0.064 (0.525) | 0.024 (0.813) | 0.044 (0.663) | 0.144 (0.153) |
| Glucose (mg/dL) | 109.77±18.53 | 165.09±23.72 | 170.17±24.23 | 180.98±16.55 | 150.06±18.18 |
| Duration of ventilation (h) | 0.154 (0.127) | 0.168 (0.094) | 0.108 (0.286) | 0.127 (0.209) | 0.123 (0.225) |
| ICU stay (h) | 0.118 (0.242) | 0.159 (0.115) | 0.077 (0.445) | 0.111 (0.271) | 0.048 (0.633) |
| Hospital stay (days) | −0.005 (0.957) | 0.116 (0.251) | 0.071 (0.480) | 0.127 (0.210) | 0.058 (0.564) |
| MODS day 1 | 0.093 (0.357) | 0.083 (0.409) | 0.092 (0.361) | 0.194 (0.053) | −0.042 (0.677) |
| MODS day 2 | 0.125 (0.215) | 0.183 (0.068) | 0.132 (0.189) | 0.099 (0.327) | 0.121 (0.229) |
| MODS day 4 | 0.150 (0.137) | 0.134 (0.184) | 0.084 (0.408) | 0.108 (0.285) | 0.136 (0.178) |
| Duration of inotrope use (h) | 0.102 (0.312) | 0.221 (0.027) | 0.106 (0.295) | 0.139 (0.167) | 0.086 (0.393) |
| Perioperative blood loss (mL) | −0.004 (0.967) | 0.118 (0.242) | 0.076 (0.454) | −0.088 (0.384) | 0.083 (0.410) |
Values of SvO2, lactate and glucose levels are indicated as mean±SD. Other values indicate Pearson correlation coefficient r with the P value from hypothesis test of correlation in brackets for continuous variable including a) duration of ventilation, b) duration of stay in ICU, c) total duration of stay in hospital, d) duration of inotrope use, and e) perioperative blood loss. For ordinal data like MODS for day 1, day 2, and day 3, Spearman's correlation coefficient (ρ) has been used with the P value from hypothesis test of correlation in brackets. The r or ρ values have been interpreted as follows: ≥7.0 implies strong correlation; 0.5-0.7 implies good correlation; 0.3-0.5 implies moderate correlation and <0.3 implies poor correlation. Associated P<0.05 implies that the correlation observed in the sample is significant and that it is most likely to hold true for the underlying population. SD: Standard deviation, ICU: Intensive Care Unit, MODS: Multiple organ dysfunction score, SvO2: Mixed venous oxygen saturation